ASX:PBP

Probiotec Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

Volume26,253 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend Yield2.23%

BetaN/A

Receive PBP News and Ratings via Email

Sign-up to receive the latest news and ratings for Probiotec and its competitors with MarketBeat's FREE daily newsletter.

About Probiotec

Probiotec Limited engages in the development, manufacture and sale of pharmaceuticals, consumer health, and nutraceutical products in Australia and internationally. The company provides contract manufacturing services for solid dose tablets, capsules, and caplets; tablets coating; blister packing; liquids, creams, gels, and ointments and suspensions; powders and powder blending; and sprays, as well as manufacturing and packaging of finished doses. It also offers analytical and stability testing services; new product formulation and production trials, and ongoing research and development services; and packaging options for human and animal nutrition products, as well as manufactures and exports a range of nutraceuticals and functional ingredient raw materials. In addition, the company provides packing services and formats, including foil, carded and clamshell blister packing, bottle filling, labelling, secondary packaging, and other services for the pharmaceutical, cosmetic, and food industries. Probiotec Limited was incorporated in 1996 and is headquartered in Laverton North, Australia.

Is Probiotec Limited's (ASX:PBP) Recent Stock Performance Influenced By Its Financials In Any Way?
August 4, 2021 | finance.yahoo.com

How Much Of Probiotec Limited (ASX:PBP) Do Insiders Own?
July 5, 2021 | finance.yahoo.com

Do Probiotec's (ASX:PBP) Earnings Warrant Your Attention?
May 26, 2021 | finance.yahoo.com

Are Insiders Buying Probiotec Limited (ASX:PBP) Stock?
April 25, 2021 | finance.yahoo.com

Probiotec (ASX:PBP) Has Rewarded Shareholders With An Exceptional 432% Total Return On Their Investment
March 25, 2021 | finance.yahoo.com

Why the IDT Australia (ASX:IDT) share price is up 150% in just 2 days
March 22, 2021 | msn.com

Is Probiotec Limited's (ASX:PBP) Shareholder Ownership Skewed Towards Insiders?
January 24, 2021 | finance.yahoo.com

Does Probiotec (ASX:PBP) Deserve A Spot On Your Watchlist?
January 4, 2021 | finance.yahoo.com

Here's What We Learned About The CEO Pay At Probiotec Limited (ASX:PBP)
January 4, 2021 | finance.yahoo.com

An Intrinsic Calculation For Probiotec Limited (ASX:PBP) Suggests It's 25% Undervalued
April 1, 2020 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange: ASX
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: N/A
Sector: Medical
Current Symbol: ASX:PBP
Previous Symbol
CUSIP: N/A
CIK: N/A
Web: www.probiotec.com.au
Phone: 61 3 9278 7555
Employees: N/A
Year Founded: N/A

Sales & Book Value

Annual Sales: $120.51 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: 16.79
Book Value: A$0.87 per share
Price / Book: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 141.80
Current Ratio: 1.53
Quick Ratio: 1.19

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: N/A
Market Cap: N/A
Next Earnings Date: N/A
Optionable: Not Optionable

MarketRank^™

Overall MarketRank^™

1.10 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Probiotec.

4.7 Community Rank

Outperform Votes
Probiotec has received 18 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Probiotec has received 8 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Probiotec has received 69.23% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Probiotec and other stocks. Vote “Outperform” if you believe PBP will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PBP will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.8 Dividend Strength

Dividend Yield
Probiotec pays a meaningful dividend of 2.23%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Probiotec does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Probiotec is 81.97%. Payout ratios above 75% are not desirable because they may not be sustainable.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Probiotec insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Probiotec (ASX:PBP) Frequently Asked Questions

What stocks does MarketBeat like better than Probiotec?: Wall Street analysts have given Probiotec a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Probiotec wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.
How were Probiotec's earnings last quarter?: Probiotec Limited (ASX:PBP) posted its quarterly earnings data on Tuesday, February, 26th. The company reported $0.02 EPS for the quarter.
View Probiotec's earnings history.
How often does Probiotec pay dividends? What is the dividend yield for Probiotec?: Probiotec declared a Final dividend on Thursday, August 26th. Investors of record on Thursday, October 7th will be paid a dividend of 0.03 per share on Thursday, October 7th. This represents a dividend yield of 1.31%. The ex-dividend date of this dividend is Wednesday, September 29th.
View Probiotec's dividend history.
Is Probiotec a good dividend stock?: Probiotec pays an annual dividend of A$0.05 per share and currently has a dividend yield of 2.23%. The dividend payout ratio of Probiotec is 81.97%. Payout ratios above 75% are not desirable because they may not be sustainable.
View Probiotec's dividend history.
Who are Probiotec's key executives?: Probiotec's management team includes the following people:
Mr. Wesley Stringer B.Comm, LLB (Hons), CPA, CEO, MD & Exec. Director
Mr. Jared Stringer B.Comm, BIT, CPA, CFO, Company Sec. & Financial Controller
Ms. Julie McIntosh, Chief Operating Officer
Mr. Alan Hong, Gen. Mang. of Accounting
Mr. Dustin Stringer, Gen. Mang. of Marketing
Who are some of Probiotec's key competitors?: Some companies that are related to Probiotec include Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Althea Group (AGH), Applied Biosciences (APPB), AusCann Group (AC8), Ayr Strategies (AYRSF), Bio-Rad Laboratories (BIO), Blueberries Medical (BBM), Can B (CANB), Cannara Biotech (LOVE), CannPal Animal Therapeutics (CP1), Cansortium (CNTMF), Chalice Brands (GLDFF) and Charlotte's Web (CWBHF).
View all of PBP's competitors.
What other stocks do shareholders of Probiotec own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Probiotec investors own include Kalium Lakes (KLL) and 5G Networks (5GN).
What is Probiotec's stock symbol?: Probiotec trades on the ASX under the ticker symbol "PBP."
How much money does Probiotec make?: Probiotec has a market capitalization of $0.00 and generates $120.51 million in revenue each year.
What is Probiotec's official website?: The official website for Probiotec is www.probiotec.com.au.
How can I contact Probiotec?: The company can be reached via phone at 61 3 9278 7555.

This page was last updated on 10/16/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Probiotec Stock Forecast, Price & News

About Probiotec

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

4.7 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment

0.8 Dividend Strength

Dividend Yield

Dividend Growth

Dividend Coverage

0.0 Company Ownership

Insider Buying vs. Insider Selling

0.0 Earnings and Valuation

Probiotec (ASX:PBP) Frequently Asked Questions

What stocks does MarketBeat like better than Probiotec?

How were Probiotec's earnings last quarter?

How often does Probiotec pay dividends? What is the dividend yield for Probiotec?

Is Probiotec a good dividend stock?

Who are Probiotec's key executives?

Who are some of Probiotec's key competitors?

What other stocks do shareholders of Probiotec own?

What is Probiotec's stock symbol?

How much money does Probiotec make?

What is Probiotec's official website?

How can I contact Probiotec?